Signature Equity Partners’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Signature Equity Partners's EW Position: Q2 2026 in Review
Signature Equity Partners increased its Edwards Lifesciences (EW) stake by 17% in Q2 2026, buying an estimated $2.01K and bringing the position to 167 shares worth $15.1K. The position accounts for 0.01% of the portfolio, ranked #731.
Signature Equity Partners first reported a position in EW in Q4 2025 and has held it in 3 quarters since. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Signature Equity Partners held 167 shares of Edwards Lifesciences worth $15.1K as of Q2 2026.
- Signature Equity Partners bought 24 Edwards Lifesciences shares in Q2 2026, an estimated $2.01K.
- Edwards Lifesciences made up 0.01% of Signature Equity Partners's portfolio in Q2 2026, its #731 holding.
- Signature Equity Partners first reported a position in Edwards Lifesciences in Q4 2025 and has held it in 3 quarters since.
- 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Signature Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.